Evaluating a Web-Based Cardiovascular Disease Risk Factor Reduction Program Among American Indians

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

149 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-02-28

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cardiovascular disease (CVD) is a serious health concern for American Indians, but there have been few behaviorally based programs to lessen CVD risk among this population. The purpose of this study is to evaluate whether a Web-based program, in addition to usual medical care, can lower CVD risk factors among American Indians who have type 2 diabetes and a high risk of developing CVD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Motivational Interviewing and Cognitive Behavioral Therapy-based Intervention for Cardiovascular Disease Prevention Amongst American Indians With Diabetic and Depressive Symptoms

NCT01892124

Cardiovascular Diseases Diabetes Mellitus, Type 2 Depression +1 more

COMPLETED NA

Reducing Diabetes Risk Factors in American Indian Children: Tribal Turning Point

NCT03573856

Overweight/Obesity

UNKNOWN NA

Community Intervention to Improve CVD Risk Factor Control in Young American Indians

NCT06230705

Cholesterol, Elevated Diabetes Mellitus

NOT_YET_RECRUITING NA

A Sugar-Sweetened Beverage Reduction Intervention for Native American Men

NCT06029517

Cardiovascular Disorder Coronary Artery Disease Diabetes Mellitus +1 more

ACTIVE_NOT_RECRUITING NA

Adaptation and Implementation of a Cherokee-based Participatory Research Project to Reduce CVD Risk

NCT06671652

Blood Pressure

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cardiovascular disease (CVD) is a leading cause of death among American Indians. Significant risk factors for CVD within the American Indian population include type 2 diabetes, tobacco use, poor dietary and physical activity habits, and poor medication and treatment adherence. Despite the fact that these risk factors can be reduced through behavior change, there have been few behaviorally based interventions aimed at American Indians to lessen their CVD risk. Research has shown that medical care is moving away from sporadic, standard doctors' office visits to a more continuous and interactive relationship with health care providers. A Web-based program that allows people to interact with remotely located doctors who can answer questions and provide advice may be beneficial at increasing treatment adherence and lowering CVD risk. This study will evaluate the use of a Web-based program at lowering CVD risk among American Indians with type 2 diabetes. Researchers will also analyze the cost-effectiveness of the Web-based program and the possible healthcare cost savings.

This 3-year study will enroll American Indian adults at high risk for CVD. Participants will be randomly assigned either to usual care at their local health facility or usual care plus the Web-based program. Participants using the Web-based program will have access to a Web site that will allow them to interact with two remotely based doctors. Participants will be able to send e-mail and instant messages to ask questions and receive information, advice, or motivational messages from the doctors. Participants will periodically enter their blood glucose test results and complete questionnaires online. Study visits, occurring twice a year for 3 years, will include blood pressure and body mass index (BMI) measurements, blood collection, and smoking status assessments.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Diseases Diabetes Mellitus, Type 2 Hypertension Obesity Tobacco Use Cessation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Participants will receive usual care from their healthcare providers and have access to a Web-based CVD risk-factor management program.

Group Type EXPERIMENTAL

Chronic disease management Web-based software

Intervention Type BEHAVIORAL

Participants will have access to remotely based medical providers through the use of the Web-based software.

B

Participants will receive usual care from their healthcare providers.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chronic disease management Web-based software

Participants will have access to remotely based medical providers through the use of the Web-based software.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

CliniPro

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Completed a baseline Education and Research Towards Health (EARTH) study examination
* Diagnosed with type 2 diabetes mellitus AND hypertension and/or hyperlipidemia
* Able to read and understand English
* Able to walk

Exclusion Criteria

* Diagnosed with CVD at study entry
* Currently receiving active treatment for any non-skin cell cancer
* Any medical condition that study physicians believe would interfere with study participation or evaluation of results
* Mental incapacity and/or cognitive impairment that would preclude adequate understanding of, or cooperation with, the study procedures
* Kidney insufficiency, as indicated by serum creatinine level greater than 2.0 mg/dL for women and greater than 2.4 mg/dL for men
* Pregnant

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No